1. AstraZeneca and Amgen get optimistic phase 3 asthma drug results — Pfizer/BioNTech begin studies for third booster dose and development of vaccine for variants — Merck KGaA in biobucks pact with Debiopharm for next-gen cancer asset See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Year End Journey Process BS

Discussion in 'Exact Sciences' started by anonymous, Jan 7, 2016 at 7:40 PM.

  1. anonymous

    anonymous Guest

    All I care about is how much I'm getting a raise in base salary. Cut out the stupid Pharma stuff. It's enough I'm being micromanaged daily here.
     
  2. anonymous

    anonymous Guest

    1 more "action item" to take away from what we should be doing...selling. Like ridiculous town hall meetings and portal certification. Enough!!!
     
  3. anonymous

    anonymous Guest

    +1